Sandra Lüttgau

Title: Sandra Lüttgau: Innovator in Binding Molecules and Protein Libraries

Introduction

Sandra Lüttgau is a prominent inventor based in Schongau, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules and methods for producing protein libraries. With a total of 3 patents, her work has the potential to impact various therapeutic applications.

Latest Patents

One of her latest patents focuses on binding molecules, especially antibodies, that bind to L1CAM (CD171). This patent describes a binding molecule capable of recognizing the same L1 epitope as the monoclonal antibody L1-OV52.24. It also details the sequences that encode the variable parts of the light and heavy chains of this antibody. Another notable patent involves a method for producing protein libraries, particularly antibody libraries, which are highly diverse and allow for the selection of specific proteins from these libraries.

Career Highlights

Throughout her career, Sandra has worked with esteemed organizations such as the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the German Cancer Research Center Foundation of Public Law (Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts). Her innovative work in these institutions has contributed to advancements in cancer research and treatment.

Collaborations

Sandra has collaborated with notable professionals in her field, including Gerhard Moldenhauer and Peter Altevogt. These partnerships have further enhanced her research and development efforts.

Conclusion

Sandra Lüttgau is a trailblazer in the field of biotechnology, with her patents paving the way for future innovations in binding molecules and protein libraries. Her contributions are invaluable to the scientific community and hold promise for therapeutic advancements.